This book will provide readers with a detailed understanding of the ischemic damage to the myocardium after myocardial infarction, as well as essential tools for the treatment of damaged heart after myocardial infarction. It discusses various methods such as pharmacological pre- and post-conditioning, cytokine therapy, and cell therapy especially using Muse cells.The coverage of Muse cell therapy, which includes the latest work done by the author and his collaborators, is a unique feature of the book. Muse cells have self-renewability and have ability to differentiate into cells with the characteristics of all three germ layers from a single cell, while they are non-tumorigenic. It is the first book to feature the Muse cell therapy, which may offer the new promising therapeutic strategy for acute myocardial infarction.
Auflage
Sprache
Verlagsort
Zielgruppe
Illustrationen
9
13 farbige Abbildungen, 9 s/w Abbildungen
VIII, 58 p. 22 illus., 13 illus. in color.
Maße
Höhe: 241 mm
Breite: 160 mm
Dicke: 11 mm
Gewicht
ISBN-13
978-981-15-0165-4 (9789811501654)
DOI
10.1007/978-981-15-0167-8
Schweitzer Klassifikation
Shinya Minatoguchi, MD, PhD
Emeritus Professor, Gifu University
Research Professor, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu City, Gifu Prefecture 501-1194, Japan
Head of Heart Failure Center, Gifu Municipal Hospital,
7-1 Kashimacho, Gifu City, Gifu Prefecture 500-8513, Japan
Chapter 1: Myocardial infarction and development of heart failure.- Chapter 2: Ischemic preconditioning.- Chapter 3: Pharmacological preconditioning.- Chapter 4: Ischemic postconditioning.- Chapter 5: Pharmacological postconditioning.- Chapter 6: Cytokine therapy.- Chapter 7: Stem cell therapy.- Chapter 8: Future application and perspectives.